This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB08123/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08123/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08123/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08123/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08123/identifier/chemspider/

Statements

Subject Item
n2:DB08123
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n12:DB08123 n13:DB08123
dcterms:title
N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
adms:identifier
n4:DB08123 n5:LS2 n8:4450813 n9:5288709 n10:99444594
n6:IUPAC-Name
n7:271B6066-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B606C-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B606B-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B6068-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B6069-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B606A-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B6064-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B6065-363D-11E5-9242-09173F13E4C5 n7:271B6062-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B6063-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B6072-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B6073-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B606D-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B606E-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B6070-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B606F-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B6071-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B6078-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B607A-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B607B-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B6077-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B6076-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B6079-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B6067-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B6074-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B6075-363D-11E5-9242-09173F13E4C5